advertisement
Trials 8
Showing records 1 to 8 | Display all abstracts in Trials105903 Factors impacting participation in research during the COVID-19 pandemic: results from a survey of patients in the ophthalmology outpatient department
Abdulhussein D
Trials 2022; 23: 823
106213 Treatment of nonarteritic anterior ischemic optic neuropathy with an endothelin antagonist: ENDOTHELION (ENDOTHELin antagonist receptor in Ischemic Optic Neuropathy)-a multicentre randomised controlled trial protocol
Chiquet C; Vignal C
Trials 2022; 23: 916
105903 Factors impacting participation in research during the COVID-19 pandemic: results from a survey of patients in the ophthalmology outpatient department
Yap TE; Manzar H
Trials 2022; 23: 823
106213 Treatment of nonarteritic anterior ischemic optic neuropathy with an endothelin antagonist: ENDOTHELION (ENDOTHELin antagonist receptor in Ischemic Optic Neuropathy)-a multicentre randomised controlled trial protocol
Gohier P
Trials 2022; 23: 916
105903 Factors impacting participation in research during the COVID-19 pandemic: results from a survey of patients in the ophthalmology outpatient department
Miodragovic S
Trials 2022; 23: 823
106213 Treatment of nonarteritic anterior ischemic optic neuropathy with an endothelin antagonist: ENDOTHELION (ENDOTHELin antagonist receptor in Ischemic Optic Neuropathy)-a multicentre randomised controlled trial protocol
Héron E
Trials 2022; 23: 916
105903 Factors impacting participation in research during the COVID-19 pandemic: results from a survey of patients in the ophthalmology outpatient department
Cordeiro F
Trials 2022; 23: 823
106213 Treatment of nonarteritic anterior ischemic optic neuropathy with an endothelin antagonist: ENDOTHELION (ENDOTHELin antagonist receptor in Ischemic Optic Neuropathy)-a multicentre randomised controlled trial protocol
Thuret G; Rougier MB; Lehmann A; Flet L; Quesada JL; Roustit M; Milea D; Pépin JL;
Trials 2022; 23: 916
